NCT01479127View on ClinicalTrials.gov

Study of Safety, Tolerability, Pharmacokinetics, and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Advanced Parkinson's Disease
Interventions
DRUG

ABT-SLV187

DRUG

Oral Levodopa/Carbidopa

Tablet; contains 100 mg levodopa and 10 mg carbidopa

DEVICE

Infusion Pump: CADD-Legacy® 1400 Pump

General infusion pump, manufactured by Smiths Medical (US)

DEVICE

NJ-Tube: Silicon ED Tube

Device used to deliver nutrition/drug to stomach/intestine or to aspirate stomach fluid, manufactured by Create Medic Co., Ltd. (Japan)

DEVICE

Adaptor: Hakko Adaptor

Accessory set for fluid infusion set, consisting of caps, connectors and adapters, etc, manufactured by Hakko Medical (Japan)

All Listed Sponsors
collaborator

Abbott Japan Co.,Ltd

INDUSTRY

lead

AbbVie (prior sponsor, Abbott)

INDUSTRY

NCT01479127 - Study of Safety, Tolerability, Pharmacokinetics, and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease | Biotech Hunter | Biotech Hunter